VacciniaStatutvaxPatNCT06616753
Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital
An observational study of Vaccinia, run by Groupe Hospitalier Sud Ile-de-France at 1 site in France.
Trial summary
The goal of this observational study is to learn about the rate of knowledge of own vaccination status among patients hospitalized at Melun hospital. The main questions it aims to answer are: the rate of knowledge of its vaccination status among patients hospitalized at Melun hospital hospitalized patients' attitude… Read more about this study
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients hospitalized at CH Melun
Who may be able to join
- French-speaking and non-demented patient : able to speak and understand French and without dementia
- Adult patient (Age ≥ 18 years)
- Main place of residence in France
- Hospitalized in a department of the CH of Melun
Who cannot join
- Does not speak French or dementia
- Patient's refusal to participate in the study
Trial locations and contacts
1 site in 1 country.
France1 site, 1 recruiting
- Recruiting
Groupe Hospitalier Sud Ïle de France
Melun, Seine Et Marne, 77000
AGHER AREZKI, +33181742228, arezki.agher@ghsif.fr
FAYALI TAKOUA, 0033181742774, takoua.fayali@ghsif.fr
About this study
Official title: Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital : Observational Trial
The goal of this observational study is to learn about the rate of knowledge of own vaccination status among patients hospitalized at Melun hospital. The main questions it aims to answer are:
- the rate of knowledge of its vaccination status among patients hospitalized at Melun hospital
- hospitalized patients' attitude to vaccination in general. Evaluate the number of patients wishing to update their vaccination status. Observe the influence of various factors (gender, occupation, presence or absence of GP, chronic illness) on vaccination status in Melun, France Participants will be asked to complete a questionnaire during hospitalization.
Read the detailed description
As part of the national "European Vaccination Week" event organized by the French Ministry of Health and Prevention, we are asking a sample of patients hospitalized in our hospital to complete a questionnaire on their knowledge of their vaccination status, and to assess their relationship with vaccination.
Questionnaire administered to patient during hospitalization (n=140 patients). Patients randomly selected by the Department of Medical Information of the hospital at the beginning of the survey week.
Patients randomly selected from each of the 10 departments of the CH of Melun (internal medicine, infectious diseases, gastroenterology, pneumology, surgery, BCR medicine, cardiology, nephrology, follow-up care and rehabilitation and geriatrics) and accompanied to complete a questionnaire set up by the Public Health Unit (USP) and Hygiene Operational Team (EOH) of the CH of Melun.
- Conditions
- Vaccinia
- Being tested
- vaccination status
- Medical subject headings
- Vaccinia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
vaccination statusBiological
knowledge of own vaccination status
What is being measured
The primary outcome is the main question the study is designed to answer.
Evaluate the rate of knowledge of own vaccination status
Measured: Day 1
Secondary outcomes (2)
Evaluate the number of patients wishing to update their vaccination status
Measured: Day 1
3.Observe the influence of various factors in vaccination status at Melun Hospital : 3.1 % of each gender 3.2 % of patients with a specefic occupation 3.3 % of patients with or without a treating physician 3.4 Rate of patients with chronic illness
Measured: Day 1
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Sep 2024
- Study start16 Jul 2024
- Primary completionOct 2025 (estimated)
- Study completionDec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for VacciniaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 140 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Groupe Hospitalier Sud Ile-de-France
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- CORALIE NOEL, Principal investigator, Groupe Hospitalier Sud Ile-de-France
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06616753
- Sponsor's protocol ID
- 2023-A01028-37
- Acronym
- StatutvaxPat
- Status last verified
- Sep 2024
- First submitted
- 15 Dec 2023
- Last updated
- 6 Jun 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 Jun 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of Patients' Knowledge of Their Vaccination Status and Their Relationship to Vaccination at Melun Hospital : Observational Trial
- ClinicalTrials.gov ID
- NCT06616753
- Acronym / sponsor ID
- StatutvaxPat / 2023-A01028-37
- Conditions
- Vaccinia
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 140 participants (estimated)
- Lead sponsor
- Groupe Hospitalier Sud Ile-de-FranceUniversity, hospital or other
- Study start
- 16 Jul 2024 (actual)
- Primary completion
- Oct 2025 (estimated)
- Study completion
- Dec 2025 (estimated)
- First posted
- 27 Sep 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this observational study is to learn about the rate of knowledge of own vaccination status among patients hospitalized at Melun hospital. The main questions it aims to answer are:
- the rate of knowledge of its vaccination status among patients hospitalized at Melun hospital
- hospitalized patients' attitude to vaccination in general. Evaluate the number of patients wishing to update their vaccination status. Observe the influence of various factors (gender, occupation, presence or absence of GP, chronic illness) on vaccination status in Melun, France Participants will be asked to complete a questionnaire during hospitalization.
Detailed description
As part of the national "European Vaccination Week" event organized by the French Ministry of Health and Prevention, we are asking a sample of patients hospitalized in our hospital to complete a questionnaire on their knowledge of their vaccination status, and to assess their relationship with vaccination.
Questionnaire administered to patient during hospitalization (n=140 patients). Patients randomly selected by the Department of Medical Information of the hospital at the beginning of the survey week.
Patients randomly selected from each of the 10 departments of the CH of Melun (internal medicine, infectious diseases, gastroenterology, pneumology, surgery, BCR medicine, cardiology, nephrology, follow-up care and rehabilitation and geriatrics) and accompanied to complete a questionnaire set up by the Public Health Unit (USP) and Hygiene Operational Team (EOH) of the CH of Melun.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients hospitalized at CH Melun
Key inclusion criteria (4 listed)
- French-speaking and non-demented patient : able to speak and understand French and without dementia
- Adult patient (Age ≥ 18 years)
- Main place of residence in France
- Hospitalized in a department of the CH of Melun
Key exclusion criteria (2 listed)
- Does not speak French or dementia
- Patient's refusal to participate in the study
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| vaccination statusknowledge of own vaccination status | Biological | – |
Primary outcome
Evaluate the rate of knowledge of own vaccination status
Time frame: Day 1
2 secondary outcomes
Evaluate the number of patients wishing to update their vaccination status
Time frame: Day 1
3.Observe the influence of various factors in vaccination status at Melun Hospital : 3.1 % of each gender 3.2 % of patients with a specefic occupation 3.3 % of patients with or without a treating physician 3.4 Rate of patients with chronic illness
Time frame: Day 1
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 Jun 2025.
Related trials for Vaccinia
RecruitingPhase 1
A Phase 1 Study of OTS-412 (Recombinant Oncolytic Vaccinia Virus) in Treatment-refractory Solid Tumor Patients (South Korea)
Treatment-Refractory Solid Tumors
RecruitingPhase 1
Oncolytic Virotherapy to Enhance PReoperative IMmunotherapy Efficacy in Patients With Proficient Mismatch Repair (pMMR) Rectal Cancer
Rectal Cancer Patients
Active, not recruitingPhase 1
Vaccine Therapy and Sargramostim in Treating Patients With Pancreas Cancer That Cannot Be Removed By Surgery
Locally Advanced Pancreatic Adenocarcinoma, Pancreatic Acinar Cell Carcinoma
Active, not recruitingEarly Phase 1
Evaluating the Human Immune Response to the JYNNEOS Vaccine
Vaccinia, Virus Diseases
RecruitingPhase 1/2
Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant
Cytomegaloviral Infection, Hematopoietic Cell Transplant Recipient
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
CORALIE NOEL principal investigator
Groupe Hospitalier Sud Ile-de-France
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Vaccinia, run by Groupe Hospitalier Sud Ile-de-France at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 6 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact CORALIE NOEL (0033181742127, coralie.noel@ghsif.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Evaluate the rate of knowledge of own vaccination status (time frame: Day 1). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jun 2025.